Fiche publication
Date publication
janvier 2025
Journal
eGastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BAUMERT Thomas
,
Dr DALI-YOUCEF Nassim
,
Dr LUPBERGER Joachim
,
Pr PESSAUX Patrick
,
Dr MUKHERJI Atish
Tous les auteurs :
Roca Suarez AA, Jühling F, Moehlin J, Mailly L, Virzì A, Brignon N, Durand SC, Oudot MA, Schaeffer E, Martin R, Meiss-Heydmann L, Bach C, Boulahtouf Z, Girard L, Osswald E, Jamey C, Brumaru D, Dali-Youcef N, Mukherji A, Saez-Palma M, Testoni B, Zoulim F, Koneru B, Fujiwara N, Hoshida Y, Felli E, Pessaux P, Tremblay ML, Parent R, Schuster C, Baumert TF, Lupberger J
Lien Pubmed
Résumé
Impaired hepatic expression of protein tyrosine phosphatase delta () is associated with increased STAT3 transcriptional activity and reduced survival from hepatocellular carcinoma in patients with chronic hepatitis C virus infection. However, the -expressing hepatic cell types, signalling pathways responsive to PTPRD and their role in non-viral liver disease are largely unknown.
Mots clés
fatty liver, liver diseases, metabolic diseases, non-alcoholic fatty liver disease
Référence
eGastroenterology. 2025 01;3(1):e100159
